In March 2026, Codexis reported that Q4 2025 revenue rose to US$38.92 million with net income of US$9.6 million, while ...
Every year, thousands of people are blinded suddenly, like Durst, by injuries to their cornea, the dome-shaped lenses that ...
A silent revolution is unfolding inside Indian laboratories. From the patent-free power of an indigenous CRISPR tool to ...
Everyday Health on MSN
The future of congenital adrenal hyperplasia (CAH) treatment: New and emerging therapies and technologies
In addition to new medications to treat this enzyme deficiency, research is underway on easier hormone sampling and fixing the gene mutation that causes CAH.
A study published in the journal Science reveals how jumping fragments of human DNA, a type of genetic parasite, destabilize ...
History is filled with remarkable stories of human ingenuity and adaptation. While most history books focus on kings, wars, ...
The leading investors, owners, developers, hoteliers, advisers and suppliers from across South East Asia were in Singapore ...
San Francisco-based biotechnology company Codexis has reported strong fourth-quarter and fiscal year 2025 financial results, with the company's focus on RNA medicine gaining significant momentum. In a ...
With a love for rugby and baseball, Kei Nakayama, Alltech's managing director for Northeast and Southeast Asia, conveys a passion for the larger agenda of sustainability in global agriculture.
The history of technology is written not just in laboratories and corporate campuses, but in the moments when the people who built ...
A facial might be a less frequent service you indulge in, but now that many of us are wearing less makeup around the house and sticking to a work-from-home skin care routine, it’s a perfect time to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results